{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:12:37Z","timestamp":1792782757624,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["18ZR1406600"],"award-info":[{"award-number":["18ZR1406600"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970531"],"award-info":[{"award-number":["81970531"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fujian Provincial Natural Science Foundation Project","award":["2021D033"],"award-info":[{"award-number":["2021D033"]}]},{"name":"Young Talents Plan for Zhongshan Hospital Fudan University","award":["2023ZSQN0099"],"award-info":[{"award-number":["2023ZSQN0099"]}],"id":[{"id":"https:\/\/ror.org\/013q1eq08","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Nod-like receptor family pyrin-containing protein 3 (NLRP3) inflammasome plays a pathologic role in metabolic dysfunction-associated steatohepatitis (MASH), but the molecular mechanism regulating the NLRP3 inflammasome activation in hepatocellular lipotoxicity remains largely unknown. Bromodomain-containing protein 4 (BRD4) has emerged as a key epigenetic reader of acetylated lysine residues in enhancer regions that control the transcription of key genes. The aim of this study is to investigate if and how BRD4 regulated the NLRP3 inflammasome activation and pyroptosis in MASH. Using the AML12 and primary mouse hepatocytes stimulated by palmitic acid (PA) as an in vitro model of hepatocellular lipotoxicity, we found that targeting BRD4 by genetic knockdown or a selective BRD4 inhibitor MS417 protected against hepatosteatosis; and this protective effect was attributed to inhibiting the activation of NLRP3 inflammasome and reducing the expression of Caspase-1, gasdermin D (GSDMD), interleukin (IL)-1\u03b2 and IL-6. Moreover, BRD4 inhibition limited the voltage-dependent anion channel-1 (VDAC1) expression and oligomerization in PA-treated AML12 hepatocytes, thereby suppressing the NLRP3 inflammasome activation. Additionally, the expression of BRD4 enhanced in MASH livers of humans. Mechanistically, BRD4 was upregulated during hepatocellular lipotoxicity that in turn modulated the active epigenetic mark H3K27ac at the promoter regions of the\n                    <jats:italic>Vdac<\/jats:italic>\n                    and\n                    <jats:italic>Gsdmd<\/jats:italic>\n                    genes, thereby enhancing the expression of VDAC and GSDMD. Altogether, our data provide novel insights into epigenetic mechanisms underlying BRD4 activating the NLRP3 inflammasome and promoting GSDMD-mediated pyroptosis in hepatocellular lipotoxicity. Thus, BRD4 might serve as a novel therapeutic target for the treatment of MASH.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphic abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s00018-024-05328-7","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T22:01:41Z","timestamp":1720476101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Targeting BRD4 mitigates hepatocellular lipotoxicity by suppressing the NLRP3 inflammasome activation and GSDMD-mediated hepatocyte pyroptosis"],"prefix":"10.1007","volume":"81","author":[{"given":"Fangyuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9106-9868","authenticated-orcid":false,"given":"Chuantao","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"key":"5328_CR1","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.cmet.2023.10.009","volume":"35","author":"K Sawada","year":"2023","unstructured":"Sawada K, Chung H, Softic S et al (2023) The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease. Cell Metab 35:1852\u20131871","journal-title":"Cell Metab"},{"key":"5328_CR2","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI (2021) Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184:2537\u20132564","journal-title":"Cell"},{"key":"5328_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster S, Cabrera D, Arrese M et al (2018) Feldstein AE. Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol 15:349\u2013364","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5328_CR4","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"5","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P (2018) Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci 5:3313\u20133327","journal-title":"Cell Mol Life Sci"},{"key":"5328_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/hep4.1479","volume":"4","author":"G Parthasarathy","year":"2020","unstructured":"Parthasarathy G, Revelo X, Malhi H (2020) Pathogenesis of nonalcoholic steatohepatitis: an overview. Hepatol Commun 4:478\u2013492","journal-title":"Hepatol Commun"},{"key":"5328_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"AR Mridha","year":"2017","unstructured":"Mridha AR, Wree A, Robertson AAB et al (2017) NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol 66:1037\u20131046","journal-title":"J Hepatol"},{"key":"5328_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","volume":"12","author":"G Szabo","year":"2015","unstructured":"Szabo G, Petrasek J (2015) Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol 12:387\u2013400","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5328_CR8","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1016\/j.celrep.2018.07.068","volume":"24","author":"CY Han","year":"2018","unstructured":"Han CY, Rho HS, Kim A et al (2018) FXR inhibits endoplasmic reticulum stress-Induced NLRP3 inflammasome in hepatocytes and ameliorates Liver Injury. Cell Rep 24:2985\u20132999","journal-title":"Cell Rep"},{"key":"5328_CR9","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1136\/gutjnl-2020-322509","volume":"70","author":"EH Koh","year":"2021","unstructured":"Koh EH, Yoon JE, Ko MS et al (2021) Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis. Gut 70:1954\u20131964","journal-title":"Gut"},{"key":"5328_CR10","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.it.2022.10.003","volume":"43","author":"A Olona","year":"2022","unstructured":"Olona A, Leishman S, Anand PK (2022) The NLRP3 inflammasome: regulation by metabolic signals. Trends Immunol 43:978\u2013989","journal-title":"Trends Immunol"},{"key":"5328_CR11","doi-asserted-by":"publisher","first-page":"167271","DOI":"10.1016\/j.jmb.2021.167271","volume":"434","author":"J Knorr","year":"2022","unstructured":"Knorr J, Wree A, Feldstein AE (2022) Pyroptosis in Steatohepatitis and Liver diseases. J Mol Biol 434:167271","journal-title":"J Mol Biol"},{"key":"5328_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature18629","volume":"535","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang Z, Ruan J et al (2016) Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535:153\u2013158","journal-title":"Nature"},{"key":"5328_CR13","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41590-023-01526-w","volume":"24","author":"P Devant","year":"2023","unstructured":"Devant P, Kagan JC (2023) Molecular mechanisms of gasdermin D pore-forming activity. Nat Immunol 24:1064\u20131075","journal-title":"Nat Immunol"},{"key":"5328_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, Yazdi AS, Menu P et al (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469:221\u2013225","journal-title":"Nature"},{"key":"5328_CR15","doi-asserted-by":"publisher","first-page":"eade7652","DOI":"10.1126\/sciimmunol.ade7652","volume":"8","author":"SH Baik","year":"2023","unstructured":"Baik SH, Ramanujan VK, Becker C et al (2023) Hexokinase dissociation from mitochondria promotes oligomerization of VDAC that facilitates NLRP3 inflammasome assembly and activation. Sci Immunol 8:eade7652","journal-title":"Sci Immunol"},{"key":"5328_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mam.2016.11.008","volume":"54","author":"J Lee","year":"2017","unstructured":"Lee J, Kim Y, Friso S et al (2017) Epigenetics in non-alcoholic fatty liver disease. Mol Aspects Med 54:78\u201388","journal-title":"Mol Aspects Med"},{"key":"5328_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrd4286","volume":"13","author":"P Filippakopoulos","year":"2014","unstructured":"Filippakopoulos P, Knapp S (2014) Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Discov 13:337\u2013356","journal-title":"Nat Rev Drug Discov"},{"key":"5328_CR18","doi-asserted-by":"publisher","first-page":"7959","DOI":"10.1093\/nar\/gkac624","volume":"50","author":"F Biagioni","year":"2022","unstructured":"Biagioni F, Croci O, Sberna S et al (2022) Decoding YAP dependent transcription in the liver. Nucleic Acids Res 50:7959\u20137971","journal-title":"Nucleic Acids Res"},{"key":"5328_CR19","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.7150\/ijbs.46153","volume":"16","author":"K Hao","year":"2020","unstructured":"Hao K, Jiang W, Zhou M et al (2020) Targeting BRD4 prevents acute gouty arthritis by regulating pyroptosis. Int J Biol Sci 16:3163\u20133173","journal-title":"Int J Biol Sci"},{"key":"5328_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.bbrc.2019.07.097","volume":"519","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Gu Y, Liu J (2019) BRD4 suppression alleviates cerebral ischemia-induced brain injury by blocking glial activation via the inhibition of inflammatory response and pyroptosis. Biochem Biophys Res Commun 519:481\u2013488","journal-title":"Biochem Biophys Res Commun"},{"key":"5328_CR21","doi-asserted-by":"crossref","unstructured":"Chen L, Zhong X, Cao W et al (2021) JQ1 as a BRD4 Inhibitor Blocks Inflammatory Pyroptosis-Related Acute Colon Injury Induced by LPS. Front Immunol. 2021;12:609319","DOI":"10.3389\/fimmu.2021.609319"},{"key":"5328_CR22","doi-asserted-by":"publisher","first-page":"15713","DOI":"10.1073\/pnas.1522163112","volume":"112","author":"N Ding","year":"2015","unstructured":"Ding N, Hah N, Yu RT et al (2015) BRD4 is a novel therapeutic target for liver fibrosis. Proc Natl Acad Sci U S A 112:15713\u201315718","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5328_CR23","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.metabol.2016.07.001","volume":"65","author":"A Yamada","year":"2016","unstructured":"Yamada A, Honma K, Mochizuki K et al (2016) BRD4 regulates fructose-inducible lipid accumulation-related genes in the mouse liver. Metabolism 65:1478\u20131488","journal-title":"Metabolism"},{"key":"5328_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/gutjnl-2019-318918","volume":"70","author":"F J\u00fchling","year":"2021","unstructured":"J\u00fchling F, Hamdane N, Crouchet E et al (2021) Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma. Gut 70:157\u2013169","journal-title":"Gut"},{"key":"5328_CR25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jhep.2020.03.023","volume":"73","author":"XQ Wu","year":"2020","unstructured":"Wu XQ, Poulsen KL, Sanz-Garcia C et al (2020) MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis. J Hepatol 73:616\u2013627","journal-title":"J Hepatol"},{"key":"5328_CR26","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/hep.21752","volume":"46","author":"S Joshi-Barve","year":"2007","unstructured":"Joshi-Barve S, Barve SS, Amancherla K et al (2007) Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46:823\u2013830","journal-title":"Hepatology"},{"key":"5328_CR27","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.molmet.2014.05.004","volume":"3","author":"RA Egnatchik","year":"2014","unstructured":"Egnatchik RA, Leamy AK, Jacobson DA et al (2014) ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload. Mol Metab 3:544\u2013553","journal-title":"Mol Metab"},{"key":"5328_CR28","doi-asserted-by":"publisher","first-page":"108888","DOI":"10.1016\/j.jnutbio.2021.108888","volume":"100","author":"S Li","year":"2022","unstructured":"Li S, Li X, Chen F et al (2022) Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction. J Nutr Biochem 100:108888","journal-title":"J Nutr Biochem"},{"key":"5328_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fmed.2020.00071","volume":"7","author":"Q Yao","year":"2020","unstructured":"Yao Q, Li S, Li X et al (2020) Myricetin modulates macrophage polarization and mitigates liver inflammation and fibrosis in a murine model of nonalcoholic steatohepatitis. Front Med (Lausanne) 7:71","journal-title":"Front Med (Lausanne)"},{"key":"5328_CR30","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","volume":"55","author":"HX Xian","year":"2022","unstructured":"Xian HX, Watari K, Sanchez-Lopez E et al (2022) Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity 55:1370\u20131385","journal-title":"Immunity"},{"key":"5328_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-020-2037-y","volume":"579","author":"J Yuan","year":"2020","unstructured":"Yuan J, Chang SY, Yin SG et al (2020) Two conserved epigenetic regulators prevent healthy ageing. Nature 579:118\u2013122","journal-title":"Nature"},{"key":"5328_CR32","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.stem.2022.01.001","volume":"29","author":"YM Jia","year":"2022","unstructured":"Jia YM, Li L, Lin YH et al (2022) In vivo CRISPR screening identifies BAZ2 chromatin remodelers as druggable regulators of mammalian liver regeneration. Cell Stem Cell 29:372\u2013385","journal-title":"Cell Stem Cell"},{"key":"5328_CR33","doi-asserted-by":"publisher","first-page":"853652","DOI":"10.3389\/fcell.2022.853652","volume":"10","author":"CH Lin","year":"2022","unstructured":"Lin CH, Kuo JC, Li D et al (2022) AZD5153, a bivalent BRD4 inhibitor, suppresses Hepatocarcinogenesis by Altering BRD4 Chromosomal Landscape and modulating the transcriptome of HCC cells. Front Cell Dev Biol 10:853652","journal-title":"Front Cell Dev Biol"},{"key":"5328_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nature09692","volume":"470","author":"A Rada-Iglesias","year":"2011","unstructured":"Rada-Iglesias A, Bajpai R, Swigut T et al (2011) A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470:279\u2013283","journal-title":"Nature"},{"key":"5328_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00018-022-04658-8","volume":"80","author":"U Keles","year":"2022","unstructured":"Keles U, Ow JR, Kuentzel KB et al (2022) Liver-derived metabolites as signaling molecules in fatty liver disease. Cell Mol Life Sci 80:4","journal-title":"Cell Mol Life Sci"},{"key":"5328_CR36","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s13105-023-00976-y","volume":"79","author":"JM Herranz","year":"2023","unstructured":"Herranz JM, L\u00f3pez-Pascual A, Claver\u00eda-Cabello A et al (2023) Comprehensive analysis of epigenetic and epitranscriptomic genes\u2019 expression in human MASLD. J Physiol Biochem 79:901\u2013924","journal-title":"J Physiol Biochem"},{"key":"5328_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12943-018-0915-9","volume":"17","author":"B Donati","year":"2018","unstructured":"Donati B, Lorenzini E, Ciarrocchi A (2018) BRD4 and Cancer: going beyond transcriptional regulation. Mol Cancer 17:164","journal-title":"Mol Cancer"},{"key":"5328_CR38","doi-asserted-by":"publisher","first-page":"e143379","DOI":"10.1172\/jci.insight.143379","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Dong X, Li G et al (2021) Brd4 modulates diet-induced obesity via PPAR\u03b3-dependent Gdf3 expression in adipose tissue macrophages. JCI Insight 6:e143379","journal-title":"JCI Insight"},{"key":"5328_CR39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","volume":"43","author":"RC Coll","year":"2022","unstructured":"Coll RC, Schroder K, Pelegr\u00edn P (2022) NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci 43:653\u2013668","journal-title":"Trends Pharmacol Sci"},{"key":"5328_CR40","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1016\/j.bbamcr.2014.03.021","volume":"1843","author":"S Weisthal","year":"2014","unstructured":"Weisthal S, Keinan N, Ben-Hail D et al (2014) Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction. Biochim Biophys Acta 1843:2270\u20132281","journal-title":"Biochim Biophys Acta"},{"key":"5328_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ceca.2017.06.007","volume":"69","author":"V Shoshan-Barmatz","year":"2018","unstructured":"Shoshan-Barmatz V, Krelin Y, Shteinfer-Kuzmine A (2018) VDAC1 functions in Ca2\u2009+\u2009homeostasis and cell life and death in health and disease. Cell Calcium 69:81\u2013100","journal-title":"Cell Calcium"},{"key":"5328_CR42","doi-asserted-by":"publisher","first-page":"e2219644120","DOI":"10.1073\/pnas.2219644120","volume":"120","author":"D Chanda","year":"2023","unstructured":"Chanda D, Thoudam T, Sinam IS et al (2023) Upregulation of the ERR\u03b3-VDAC1 axis underlies the molecular pathogenesis of pancreatitis. Proc Natl Acad Sci U S A 120:e2219644120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5328_CR43","doi-asserted-by":"publisher","first-page":"111304","DOI":"10.1016\/j.celrep.2022.111304","volume":"40","author":"G Yan","year":"2022","unstructured":"Yan G, Luna A, Wang H et al (2022) BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancer. Cell Rep 40:111304","journal-title":"Cell Rep"},{"key":"5328_CR44","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1111\/febs.16580","volume":"290","author":"A Kotekar","year":"2023","unstructured":"Kotekar A, Singh AK, Devaiah BN (2023) BRD4 and MYC: power couple in transcription and disease. FEBS J 290:4820\u20134842","journal-title":"FEBS J"},{"key":"5328_CR45","doi-asserted-by":"publisher","first-page":"21931","DOI":"10.1073\/pnas.1016071107","volume":"107","author":"MP Creyghton","year":"2010","unstructured":"Creyghton MP, Cheng AW, Welstead GG et al (2010) Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 107:21931\u201321936","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5328_CR46","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.immuni.2024.03.012","volume":"57","author":"B Sundaram","year":"2024","unstructured":"Sundaram B, Tweedell RE, Prasanth Kumar S et al (2024) The NLR family of innate immune and cell death sensors. Immunity 57:674\u2013699","journal-title":"Immunity"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05328-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-024-05328-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05328-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:01:48Z","timestamp":1720483308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-024-05328-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5328"],"URL":"https:\/\/doi.org\/10.1007\/s00018-024-05328-7","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All subjects gave written informed consent according to the Declaration of Helsinki, and the protocol, approved by ethical committees from Shanghai Public Health Clinical Center (#2022-S104-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors involved in this manuscript give the consent for the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"295"}}